agilon health (NYSE:AGL) Stock Price Down 7.9% – Should You Sell?

agilon health, inc. (NYSE:AGL)’s stock price fell 7.9% during mid-day trading on Thursday . The company traded as low as $3.25 and last traded at $3.23. 2,021,142 shares were traded during trading, a decline of 60% from the average session volume of 5,055,943 shares. The stock had previously closed at $3.50.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on AGL. Needham & Company LLC began coverage on agilon health in a research report on Friday, January 10th. They set a “hold” rating for the company. JMP Securities lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, November 11th. TD Cowen cut their price target on agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a report on Monday, November 11th. Royal Bank of Canada restated an “outperform” rating and set a $3.00 price objective on shares of agilon health in a report on Tuesday, November 19th. Finally, Citigroup upgraded shares of agilon health from a “sell” rating to a “neutral” rating and boosted their price target for the company from $1.75 to $2.25 in a research note on Friday, January 10th. Two equities research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and two have issued a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $4.03.

agilon health Stock Performance

The company’s 50 day simple moving average is $2.56 and its 200 day simple moving average is $3.34. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The stock has a market cap of $1.37 billion, a PE ratio of -3.55 and a beta of 0.67.

agilon health (NYSE:AGL) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The business had revenue of $1.45 billion for the quarter, compared to the consensus estimate of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same quarter last year, the business posted ($0.06) earnings per share. Analysts expect that agilon health, inc. will post -0.59 earnings per share for the current year.

Insider Activity

In related news, Director John William Wulf bought 45,000 shares of agilon health stock in a transaction dated Thursday, December 5th. The stock was purchased at an average cost of $2.18 per share, with a total value of $98,100.00. Following the transaction, the director now directly owns 206,133 shares of the company’s stock, valued at approximately $449,369.94. The trade was a 27.93 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Diana Mckenzie purchased 12,500 shares of the stock in a transaction that occurred on Monday, November 25th. The stock was bought at an average cost of $2.28 per share, for a total transaction of $28,500.00. Following the acquisition, the director now directly owns 51,319 shares in the company, valued at $117,007.32. This trade represents a 32.20 % increase in their position. The disclosure for this purchase can be found here. Insiders acquired a total of 90,000 shares of company stock valued at $198,100 in the last ninety days. 3.20% of the stock is currently owned by insiders.

Institutional Trading of agilon health

Large investors have recently bought and sold shares of the company. JPMorgan Chase & Co. boosted its position in agilon health by 326.4% during the third quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock worth $5,563,000 after purchasing an additional 1,083,492 shares during the period. Inspire Investing LLC grew its stake in agilon health by 106.6% in the 4th quarter. Inspire Investing LLC now owns 217,550 shares of the company’s stock valued at $413,000 after buying an additional 112,241 shares in the last quarter. Citigroup Inc. lifted its position in shares of agilon health by 2,251.5% during the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after acquiring an additional 1,941,993 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of agilon health by 1.2% in the third quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock worth $27,097,000 after acquiring an additional 84,889 shares during the period. Finally, State Street Corp grew its position in shares of agilon health by 3.0% in the third quarter. State Street Corp now owns 7,449,706 shares of the company’s stock valued at $29,277,000 after purchasing an additional 215,733 shares in the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.